Literature DB >> 33099483

Genetic Analysis Identifies the Role of HLF in Renal Cell Carcinoma.

Chao-Yuan Huang1, Shu-Pin Huang2,3,4,5, Yu-Mei Hsueh6,7, Lih-Chyang Chen8, Te-Ling Lu9, Bo-Ying Bao10,11,12.   

Abstract

BACKGROUND/AIM: Circadian rhythm is an internal clock that regulates the cycles of many biological functions. Epidemiological studies have linked aberrant circadian rhythm to an increased susceptibility to cancer and poor patient prognosis. However, there remains a gap in our understanding of genetic variants related to the circadian pathway in renal cell carcinoma (RCC) progression. PATIENTS AND METHODS: We examined the associations of 150 single nucleotide polymorphisms (SNPs) in 12 core circadian pathway genes with RCC risk and survival in 630 patients with RCC and controls.
RESULTS: After adjusting for multiple comparisons and performing multivariate analyses, we found that the HLF rs6504958 polymorphism was significantly associated with RCC risk (q<0.05), whereas, no SNP association was significant for survival. Furthermore, the rs6504958 G allele was associated with reduced expression of HLF; consequently, a lower HLF expression was correlated with more advanced RCC. Moreover, a meta-analysis of six kidney cancer gene expression datasets demonstrated that an elevated HLF expression was associated with a favorable prognosis in patients with RCC (hazard ratio=0.70, 95% confidence interval=0.65-0.76, p<0.001).
CONCLUSION: These findings implicate the potential protective role of HLF in the progression of RCC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Renal cell carcinoma; circadian rhythm; metastasis-free survival; overall survival; single nucleotide polymorphism

Mesh:

Substances:

Year:  2020        PMID: 33099483      PMCID: PMC7675652          DOI: 10.21873/cgp.20236

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  34 in total

Review 1.  Working against our endogenous circadian clock: Breast cancer and electric lighting in the modern world.

Authors:  Richard G Stevens
Journal:  Mutat Res       Date:  2009 Nov-Dec       Impact factor: 2.433

2.  Polymorphisms in circadian genes, night work and breast cancer: results from the GENICA study.

Authors:  Sylvia Rabstein; Volker Harth; Christina Justenhoven; Beate Pesch; Sabine Plöttner; Evelyn Heinze; Anne Lotz; Christian Baisch; Markus Schiffermann; Hiltrud Brauch; Ute Hamann; Yon Ko; Thomas Brüning
Journal:  Chronobiol Int       Date:  2014-09-17       Impact factor: 2.877

Review 3.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

4.  Night-shift work and risk of colorectal cancer in the nurses' health study.

Authors:  Eva S Schernhammer; Francine Laden; Frank E Speizer; Walter C Willett; David J Hunter; Ichiro Kawachi; Charles S Fuchs; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2003-06-04       Impact factor: 13.506

5.  The DBP gene is expressed according to a circadian rhythm in the suprachiasmatic nucleus and influences circadian behavior.

Authors:  L Lopez-Molina; F Conquet; M Dubois-Dauphin; U Schibler
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

6.  Molecular clock is involved in predictive circadian adjustment of renal function.

Authors:  Annie Mercier Zuber; Gabriel Centeno; Sylvain Pradervand; Svetlana Nikolaeva; Lionel Maquelin; Léonard Cardinaux; Olivier Bonny; Dmitri Firsov
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-09       Impact factor: 11.205

7.  Gene expression profiling predicts survival in conventional renal cell carcinoma.

Authors:  Hongjuan Zhao; Börje Ljungberg; Kjell Grankvist; Torgny Rasmuson; Robert Tibshirani; James D Brooks
Journal:  PLoS Med       Date:  2005-12-06       Impact factor: 11.069

8.  Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression.

Authors:  Chia-Cheng Yu; Lih-Chyang Chen; Chih-Yung Chiou; Yu-Jia Chang; Victor C Lin; Chao-Yuan Huang; I-Ling Lin; Ta-Yuan Chang; Te-Ling Lu; Cheng-Hsueh Lee; Shu-Pin Huang; Bo-Ying Bao
Journal:  Cancer Cell Int       Date:  2019-04-05       Impact factor: 5.722

9.  HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease.

Authors:  Lucas D Ward; Manolis Kellis
Journal:  Nucleic Acids Res       Date:  2015-12-10       Impact factor: 16.971

10.  Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

Authors:  Heather S L Jim; Hui-Yi Lin; Jonathan P Tyrer; Kate Lawrenson; Joe Dennis; Ganna Chornokur; Zhihua Chen; Ann Y Chen; Jennifer Permuth-Wey; Katja Kh Aben; Hoda Anton-Culver; Natalia Antonenkova; Fiona Bruinsma; Elisa V Bandera; Yukie T Bean; Matthias W Beckmann; Maria Bisogna; Line Bjorge; Natalia Bogdanova; Louise A Brinton; Angela Brooks-Wilson; Clareann H Bunker; Ralf Butzow; Ian G Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Cezary Cybulski; Agnieszka Dansonka-Mieszkowska; Andreas du Bois; Evelyn Despierre; Weiva Sieh; Jennifer A Doherty; Thilo Dörk; Matthias Dürst; Douglas F Easton; Diana M Eccles; Robert P Edwards; Arif B Ekici; Peter A Fasching; Brooke L Fridley; Yu-Tang Gao; Aleksandra Gentry-Maharaj; Graham G Giles; Rosalind Glasspool; Marc T Goodman; Jacek Gronwald; Philipp Harter; Hanis N Hasmad; Alexander Hein; Florian Heitz; Michelle A T Hildebrandt; Peter Hillemanns; Claus K Hogdall; Estrid Hogdall; Satoyo Hosono; Edwin S Iversen; Anna Jakubowska; Allan Jensen; Bu-Tian Ji; Beth Y Karlan; Melissa Kellar; Lambertus A Kiemeney; Camilla Krakstad; Susanne K Kjaer; Jolanta Kupryjanczyk; Robert A Vierkant; Diether Lambrechts; Sandrina Lambrechts; Nhu D Le; Alice W Lee; Shashi Lele; Arto Leminen; Jenny Lester; Douglas A Levine; Dong Liang; Boon Kiong Lim; Jolanta Lissowska; Karen Lu; Jan Lubinski; Lene Lundvall; Leon F A G Massuger; Keitaro Matsuo; Valerie McGuire; John R McLaughlin; Ian McNeish; Usha Menon; Roger L Milne; Francesmary Modugno; Lotte Thomsen; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; Ursula Eilber; Kunle Odunsi; Sara H Olson; Irene Orlow; Sandra Orsulic; Rachel Palmieri Weber; James Paul; Celeste L Pearce; Tanja Pejovic; Liisa M Pelttari; Malcolm C Pike; Elizabeth M Poole; Eva Schernhammer; Harvey A Risch; Barry Rosen; Mary Anne Rossing; Joseph H Rothstein; Anja Rudolph; Ingo B Runnebaum; Iwona K Rzepecka; Helga B Salvesen; Ira Schwaab; Xiao-Ou Shu; Yurii B Shvetsov; Nadeem Siddiqui; Honglin Song; Melissa C Southey; Beata Spiewankiewicz; Lara Sucheston-Campbell; Soo-Hwang Teo; Kathryn L Terry; Pamela J Thompson; Ingvild L Tangen; Shelley S Tworoger; Anne M van Altena; Ignace Vergote; Christine S Walsh; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Kristine G Wicklund; Lynne R Wilkens; Anna H Wu; Xifeng Wu; Yin-Ling Woo; Hannah Yang; Wei Zheng; Argyrios Ziogas; Ernest Amankwah; Andrew Berchuck; Joellen M Schildkraut; Linda E Kelemen; Susan J Ramus; Alvaro N A Monteiro; Ellen L Goode; Steven A Narod; Simon A Gayther; Paul D P Pharoah; Thomas A Sellers; Catherine M Phelan
Journal:  J Genet Genome Res       Date:  2015-09-15
View more
  3 in total

1.  Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.

Authors:  Dongjun Dai; Yinglu Guo; Yongjie Shui; Jinfan Li; Biao Jiang; Qichun Wei
Journal:  Front Mol Biosci       Date:  2021-12-14

2.  Effects and Prognostic Values of Circadian Genes CSNK1E/GNA11/KLF9/THRAP3 in Kidney Renal Clear Cell Carcinoma via a Comprehensive Analysis.

Authors:  Shujing Li; Xianggang Wang; Qingqing Wang; Kaixin Ding; Xin Chen; Yun Zhao; Yu Gao; Yuanyuan Wang
Journal:  Bioengineering (Basel)       Date:  2022-07-11

3.  Genetic Analysis Implicates Dysregulation of SHANK2 in Renal Cell Carcinoma Progression.

Authors:  Chi-Fen Chang; Shu-Pin Huang; Yu-Mei Hsueh; Jiun-Hung Geng; Chao-Yuan Huang; Bo-Ying Bao
Journal:  Int J Environ Res Public Health       Date:  2022-09-30       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.